Cargando…
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
BACKGROUND: The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science ;, The Lancet Pub. Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554486/ https://www.ncbi.nlm.nih.gov/pubmed/34756186 http://dx.doi.org/10.1016/S1473-3099(21)00648-4 |
_version_ | 1784591810776006656 |
---|---|
author | Singanayagam, Anika Hakki, Seran Dunning, Jake Madon, Kieran J Crone, Michael A Koycheva, Aleksandra Derqui-Fernandez, Nieves Barnett, Jack L Whitfield, Michael G Varro, Robert Charlett, Andre Kundu, Rhia Fenn, Joe Cutajar, Jessica Quinn, Valerie Conibear, Emily Barclay, Wendy Freemont, Paul S Taylor, Graham P Ahmad, Shazaad Zambon, Maria Ferguson, Neil M Lalvani, Ajit |
author_facet | Singanayagam, Anika Hakki, Seran Dunning, Jake Madon, Kieran J Crone, Michael A Koycheva, Aleksandra Derqui-Fernandez, Nieves Barnett, Jack L Whitfield, Michael G Varro, Robert Charlett, Andre Kundu, Rhia Fenn, Joe Cutajar, Jessica Quinn, Valerie Conibear, Emily Barclay, Wendy Freemont, Paul S Taylor, Graham P Ahmad, Shazaad Zambon, Maria Ferguson, Neil M Lalvani, Ajit |
author_sort | Singanayagam, Anika |
collection | PubMed |
description | BACKGROUND: The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community. METHODS: Between Sept 13, 2020, and Sept 15, 2021, 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days. Household and non-household exposed contacts aged 5 years or older were eligible for recruitment if they could provide informed consent and agree to self-swabbing of the upper respiratory tract. We analysed transmission risk by vaccination status for 231 contacts exposed to 162 epidemiologically linked delta variant-infected index cases. We compared viral load trajectories from fully vaccinated individuals with delta infection (n=29) with unvaccinated individuals with delta (n=16), alpha (B.1.1.7; n=39), and pre-alpha (n=49) infections. Primary outcomes for the epidemiological analysis were to assess the secondary attack rate (SAR) in household contacts stratified by contact vaccination status and the index cases’ vaccination status. Primary outcomes for the viral load kinetics analysis were to detect differences in the peak viral load, viral growth rate, and viral decline rate between participants according to SARS-CoV-2 variant and vaccination status. FINDINGS: The SAR in household contacts exposed to the delta variant was 25% (95% CI 18–33) for fully vaccinated individuals compared with 38% (24–53) in unvaccinated individuals. The median time between second vaccine dose and study recruitment in fully vaccinated contacts was longer for infected individuals (median 101 days [IQR 74–120]) than for uninfected individuals (64 days [32–97], p=0·001). SAR among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% [95% CI 15–35] for vaccinated vs 23% [15–31] for unvaccinated). 12 (39%) of 31 infections in fully vaccinated household contacts arose from fully vaccinated epidemiologically linked index cases, further confirmed by genomic and virological analysis in three index case–contact pairs. Although peak viral load did not differ by vaccination status or variant type, it increased modestly with age (difference of 0·39 [95% credible interval –0·03 to 0·79] in peak log(10) viral load per mL between those aged 10 years and 50 years). Fully vaccinated individuals with delta variant infection had a faster (posterior probability >0·84) mean rate of viral load decline (0·95 log(10) copies per mL per day) than did unvaccinated individuals with pre-alpha (0·69), alpha (0·82), or delta (0·79) variant infections. Within individuals, faster viral load growth was correlated with higher peak viral load (correlation 0·42 [95% credible interval 0·13 to 0·65]) and slower decline (–0·44 [–0·67 to –0·18]). INTERPRETATION: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts. Host–virus interactions early in infection may shape the entire viral trajectory. FUNDING: National Institute for Health Research. |
format | Online Article Text |
id | pubmed-8554486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Science ;, The Lancet Pub. Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-85544862021-10-29 Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study Singanayagam, Anika Hakki, Seran Dunning, Jake Madon, Kieran J Crone, Michael A Koycheva, Aleksandra Derqui-Fernandez, Nieves Barnett, Jack L Whitfield, Michael G Varro, Robert Charlett, Andre Kundu, Rhia Fenn, Joe Cutajar, Jessica Quinn, Valerie Conibear, Emily Barclay, Wendy Freemont, Paul S Taylor, Graham P Ahmad, Shazaad Zambon, Maria Ferguson, Neil M Lalvani, Ajit Lancet Infect Dis Articles BACKGROUND: The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading globally, including in populations with high vaccination rates. We aimed to investigate transmission and viral load kinetics in vaccinated and unvaccinated individuals with mild delta variant infection in the community. METHODS: Between Sept 13, 2020, and Sept 15, 2021, 602 community contacts (identified via the UK contract-tracing system) of 471 UK COVID-19 index cases were recruited to the Assessment of Transmission and Contagiousness of COVID-19 in Contacts cohort study and contributed 8145 upper respiratory tract samples from daily sampling for up to 20 days. Household and non-household exposed contacts aged 5 years or older were eligible for recruitment if they could provide informed consent and agree to self-swabbing of the upper respiratory tract. We analysed transmission risk by vaccination status for 231 contacts exposed to 162 epidemiologically linked delta variant-infected index cases. We compared viral load trajectories from fully vaccinated individuals with delta infection (n=29) with unvaccinated individuals with delta (n=16), alpha (B.1.1.7; n=39), and pre-alpha (n=49) infections. Primary outcomes for the epidemiological analysis were to assess the secondary attack rate (SAR) in household contacts stratified by contact vaccination status and the index cases’ vaccination status. Primary outcomes for the viral load kinetics analysis were to detect differences in the peak viral load, viral growth rate, and viral decline rate between participants according to SARS-CoV-2 variant and vaccination status. FINDINGS: The SAR in household contacts exposed to the delta variant was 25% (95% CI 18–33) for fully vaccinated individuals compared with 38% (24–53) in unvaccinated individuals. The median time between second vaccine dose and study recruitment in fully vaccinated contacts was longer for infected individuals (median 101 days [IQR 74–120]) than for uninfected individuals (64 days [32–97], p=0·001). SAR among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% [95% CI 15–35] for vaccinated vs 23% [15–31] for unvaccinated). 12 (39%) of 31 infections in fully vaccinated household contacts arose from fully vaccinated epidemiologically linked index cases, further confirmed by genomic and virological analysis in three index case–contact pairs. Although peak viral load did not differ by vaccination status or variant type, it increased modestly with age (difference of 0·39 [95% credible interval –0·03 to 0·79] in peak log(10) viral load per mL between those aged 10 years and 50 years). Fully vaccinated individuals with delta variant infection had a faster (posterior probability >0·84) mean rate of viral load decline (0·95 log(10) copies per mL per day) than did unvaccinated individuals with pre-alpha (0·69), alpha (0·82), or delta (0·79) variant infections. Within individuals, faster viral load growth was correlated with higher peak viral load (correlation 0·42 [95% credible interval 0·13 to 0·65]) and slower decline (–0·44 [–0·67 to –0·18]). INTERPRETATION: Vaccination reduces the risk of delta variant infection and accelerates viral clearance. Nonetheless, fully vaccinated individuals with breakthrough infections have peak viral load similar to unvaccinated cases and can efficiently transmit infection in household settings, including to fully vaccinated contacts. Host–virus interactions early in infection may shape the entire viral trajectory. FUNDING: National Institute for Health Research. Elsevier Science ;, The Lancet Pub. Group 2022-02 /pmc/articles/PMC8554486/ /pubmed/34756186 http://dx.doi.org/10.1016/S1473-3099(21)00648-4 Text en © 2021 The Author(s). Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles Singanayagam, Anika Hakki, Seran Dunning, Jake Madon, Kieran J Crone, Michael A Koycheva, Aleksandra Derqui-Fernandez, Nieves Barnett, Jack L Whitfield, Michael G Varro, Robert Charlett, Andre Kundu, Rhia Fenn, Joe Cutajar, Jessica Quinn, Valerie Conibear, Emily Barclay, Wendy Freemont, Paul S Taylor, Graham P Ahmad, Shazaad Zambon, Maria Ferguson, Neil M Lalvani, Ajit Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study |
title | Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study |
title_full | Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study |
title_fullStr | Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study |
title_full_unstemmed | Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study |
title_short | Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study |
title_sort | community transmission and viral load kinetics of the sars-cov-2 delta (b.1.617.2) variant in vaccinated and unvaccinated individuals in the uk: a prospective, longitudinal, cohort study |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554486/ https://www.ncbi.nlm.nih.gov/pubmed/34756186 http://dx.doi.org/10.1016/S1473-3099(21)00648-4 |
work_keys_str_mv | AT singanayagamanika communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT hakkiseran communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT dunningjake communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT madonkieranj communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT cronemichaela communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT koychevaaleksandra communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT derquifernandeznieves communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT barnettjackl communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT whitfieldmichaelg communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT varrorobert communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT charlettandre communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT kundurhia communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT fennjoe communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT cutajarjessica communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT quinnvalerie communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT conibearemily communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT barclaywendy communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT freemontpauls communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT taylorgrahamp communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT ahmadshazaad communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT zambonmaria communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT fergusonneilm communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT lalvaniajit communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy AT communitytransmissionandviralloadkineticsofthesarscov2deltab16172variantinvaccinatedandunvaccinatedindividualsintheukaprospectivelongitudinalcohortstudy |